PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26248188-11	2015	Diaphragms from P-188 NF or prednisone treated mdx and dko mice showed signs of muscle fiber protection including less centralized nuclei, less variation in fiber size, greater fiber density, and exhibited a decreased amount of collagen deposition.	Prednisone	28-38	dystrophin, muscular dystrophy	Mus musculus	47-50	
32785240-7	2020	In addition, the treatments with PBMT (p = 0.0005), PBMT plus prednisone (p = 0.0048) and PBMT plus NSAID (p = 0.0021) increased dystrophin gene expression compared to placebo-control group.	Prednisone	62-72	dystrophin, muscular dystrophy	Mus musculus	129-139	
30716510-5	2019	Five-weeks of prednisone treatment in Mdx mice decreased cortical bone thickness and area (p < 0.001), with a large increase in endocortical osteoclasts that were significantly improved by PTH treatment (p < 0.001).	Prednisone	14-24	dystrophin, muscular dystrophy	Mus musculus	38-41	
30716510-8	2019	Prednisone improved grip strength and endurance of treadmill running, which were maintained and further improved, respectively, in co-treated Mdx mice.	Prednisone	0-10	dystrophin, muscular dystrophy	Mus musculus	142-145	
30302533-6	2019	Mdx mice treated with prednisone had improved muscle function that was not changed by pamidronate treatment.	Prednisone	22-32	dystrophin, muscular dystrophy	Mus musculus	0-3	
30302533-8	2019	Both 2 and 6 week pamidronate treatment increased cortical thickness and bone area compared to prednisone-treated Mdx mice, however, only 2 week pamidronate treatment improved the strength of cortical bone compared to that of glucocorticoid-treated Mdx mice.	Prednisone	95-105	dystrophin, muscular dystrophy	Mus musculus	114-117	
23846963-7	2013	The prednisone-mediated increase in alpha7 integrin was associated with increased laminin-alpha2 in prednisone-treated dystrophin-deficient muscle.	Prednisone	4-14	dystrophin, muscular dystrophy	Mus musculus	119-129	
23846963-7	2013	The prednisone-mediated increase in alpha7 integrin was associated with increased laminin-alpha2 in prednisone-treated dystrophin-deficient muscle.	Prednisone	100-110	dystrophin, muscular dystrophy	Mus musculus	119-129	
23846963-8	2013	Together, our results suggest that prednisone acts in part through increased merosin in the muscle basal lamina and through sarcolemmal stabilization of alpha7beta1 integrin in dystrophin-deficient muscle.	Prednisone	35-45	dystrophin, muscular dystrophy	Mus musculus	177-187